Anika Therapeutics Director Executes Substantial Common Stock Purchase
A recent regulatory filing has revealed that John B. Henneman, III, a member of the board of directors at Anika Therapeutics, Inc. (NASDAQ: ANIK), has increased his stake in the company through a direct purchase of common stock. The transaction, documented in a Form 4 filed with the Securities and Exchange Commission, highlights recent insider acti…